Le Lézard
Classified in: Health
Subjects: NPT, CHI, CSR, FVT

Starlight Children's Foundation Launches the Power of Play campaign to raise funds to help advance its mission


Starlight's vital programs are needed in hospitals to unleash the healing power of play

LOS ANGELES, March 1, 2024 /PRNewswire/ -- Starlight Children's Foundation is pleased to announce the launch of its Power of Play campaign, aimed at raising funds and awareness of the healing power of play for kids in hospitals and their families. The month-long campaign aims to raise $225,000 through different activations, including its annual Stream For Starlight Spring Stream event, starting on March 1.

When play is at the heart of a child's treatment, it can have a substantial positive effect.

"Hospitalization can be scary and stressful for kids. At Starlight, we work to transform the hospital experience through programs that provide therapeutic play and positive distractions, uplift spirits and empower kids with a renewed sense of optimism and courage. Studies show that happiness can help patients recover faster and with fewer complications," said Adam Garone, CEO of Starlight Children's Foundation. "This important fundraising campaign supports our mission of delivering happiness to hospitalized kids and their families, helping make the journey to recovery a little brighter."

Play is an essential part of childhood. But for hospitalized kids, it may look different. When play is at the heart of a child's treatment, it can have a substantial positive effect, from reducing pain levels to helping kids comply with treatments.

Through longstanding partnerships, including Nintendo of America and Radio Flyer, among others, Starlight offers its vital programs ? like Starlight Gaming, Starlight Radio Flyer Hero Wagons, Starlight Hospital Gowns, Starlight Virtual Reality and toy deliveries ? free of charge to its nationwide network of children's hospitals and healthcare facilities. Funds raised through the Power of Play campaign will go toward placing Starlight programs at partner hospitals across the country.

Key Highlights of the Power of Play Campaign:

Starlight Children's Foundation invites individuals, corporations, and the community to support Starlight's Power of Play campaign and make a lasting impact on the lives of children facing illness.

To learn more about the campaign or make a contribution, visit starlight.org/play.

About Starlight Children's Foundation 
Hospital stays can be lonely, stressful, and scary. That's why Starlight exists. Founded in 1982, Starlight Children's Foundation is a 501(c)3 organization that aims to deliver happiness to seriously ill children and their families through vital programs that impact millions of kids annually. Donor-funded and offered free of charge to hospitals and families, Starlight programs unleash the power of play, empowering kids with a renewed sense of optimism, resilience, and courage. Starlight is a top-rated charity committed to the equitable allocation of programs to its nationwide hospital network. Happy kids heal faster.

Learn more at starlight.org and follow Starlight on social media @starlightchildrensfoundation.

 

SOURCE Starlight Children's Foundation


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: